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1 Pediatrics, University of Kentucky, Lexington, KY, United States, 2Division of Pediatric Gastroenterology, New Hampshire’s
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Background: Limited studies are done regarding ability to produce gastric acid in
preterm infants and most studies used in vivo method of assessing gastric pH.
Objectives: To assess the feasibility of using an in vitro method of measuring gastric
pH in babies ≤ 28 weeks gestational age (GA) and determine whether changes in gastric
pH differ with gestational age, mode of delivery, and use of antenatal steroids.
Design/Methods: Prospective study that enrolled extremely low birth weight (ELBW)
babies. Gastric aspirate collected before feeding. In vitro testing of gastric aspirates for
pH were done on days of life 1, 3, 5, 7, 14, and 28 by using pH electrode. The pH
was measured on each sample in triplicate, mean calculated and used for data analysis.
Stastical methods included descriptive statistics, t-tests and repeatedmeasures ANOVA.
Results: 29 subjects≤ 28 weeks or birth weight≤ 1,000 g were enrolled. No significant
change was noted in pH measurements over time. Antenatal steroids and mode of
delivery did not affect gastric acid pH.
Conclusion: The in vitro method for gastric pH measurements is non-invasive and
affords more frequent testing. It would be useful in studying various conditions that may
affect gastric pH.
Keywords: preterm infants, gastric pH, progression of acidity, reflux, Invitro method
INTRODUCTION
The use of antacid agents to treat gastroesophageal reflux in preterm infants is common. The gold
standard for pH measurement is relatively invasive and can only be performed in larger infants.
Hence, the vast majority of neonatologists start acid suppression empirically without a diagnostic
study or work up (1). However, acid suppression in this patient population is not benign with
rising evidence linking use with significant morbidities such as sepsis and necrotizing enterocolitis
(1). Acid suppression should be very selective and limited to symptomatic patients with increased
gastric acidity.
The reference values and natural progression of gastric pH in extremely preterm infants
is poorly studied. This is a prospective study in extremely preterm babies by using an
in vitro method of assessing gastric pH changes during the first month of life. Earlier
studies used in vivo method to study development of gastric secretory process in preterm
infants in assessing gastric pH (2–4). At birth gastric pH is >2 and decreases as the
stomach begins to secrete acid. Most studies indicate that acid secretion increases from
birth to day 10, then declines again over the next 20 days. Report show that antenatal
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TABLE 1 | Mean pH and Standard deviation (SD) over period of time by Gestational age (GA).
Characteristics Day 1 Day 3 Day 5 Day 7 Day 14 Day 21 Day 28
All infants 5.28
(2.66)
4.38
(1.17)
4.36
(1.64)
3.65
(1.48)
3.92
(1.39)
4.17
(1.16)
4.69
(1.22)
GA ≥ 26 weeks
(N = 17)
5.25
(3.00)
4.5
(1.79)
4.34
(1.69)
3.29
(1.49)
3.9
(1.59)
4.1
(1.23)
4.56
(1.34)
GA < 26 weeks
(N = 12)
5.33
(2.17)
4.21
(1.60)
4.39
(1.56)
4.17
(1.47)
3.94
(1.10)
4.27
(1.05)
4.87
(1.06)
steroid use is associated with increased gastro-esophageal reflux
in preterm neonates and pH is significantly lower after vaginal
delivery than after cesarean section (5, 6). Earlier studies have
used continuous pH measurements, but in a small number of
patients. The objective of the study were to assess the feasibility
of using an in vitro method of measuring gastric pH in babies ≤
28 weeks ‘gestational age (GA) and determine whether changes in
gastric pH differ with GA, mode of delivery, and use of antenatal
steroids.
METHODS/DESIGN
This was a prospective study (between 2010-2012) that was
approved by the Institutional Review Board and complied with
applicable HIPPA standards. Informed consent was obtained
from the parent(s) prior to enrollment. Inclusion criteria
included admission to the neonatal intensive care unit, GA ≤
28 weeks and birth weight (BW) ≤ 1,000 g, and infants had
nasogastric (NG) tube as part of standard care. Exclusion criteria
were major congenital anomalies (such as congenital heart
disease, gastroschisis, and omphalocele), non-English speaking
parents, or parents < 18 years of age. Gastric aspirate was
collected through NG tube before feeding on days of life 1, 3,
5, 7, 14, 21, and 28. The pH measurement stopped at 28 days
of life as some infants will already be on full feeds without NG
tube. The specimen was collected by research staff, transported
on ice, stored, and tested at a later time. In vitro testing of gastric
aspirates for pH was done, using a solid state PHR-46 Micro
combination pH electrode (Lazar Research Laboratories, Inc.,
Los Angeles, CA, USA); this instrument has been used in earlier
studies to detect pH of body fluids (7). We utilized a neutral pH
solution to calibrate the electrode before each measurement. The
pH was measured on each sample in triplicates.
Statistical Analysis
The mean pH measured on each sample in triplicate was
calculated and used for data analysis. Coefficient of variation
(CV) was employed to determine percent variability among
triplicate measurements. Data was analyzed using SAS v9.2
(Cary, NC). Means and standard deviations (SD) were calculated
from continuous variables. To determine differences in gastric
pH by GA, antenatal steroid use and mode of delivery for each
time period, independent two sample t-tests were employed.
Repeated measure ANOVAwas employed to determine the effect
GA on gastric pH over time.
RESULTS
Twenty-nine subjects (19 males and 10 females) were enrolled.
All were≤ 28weeks and had BW≤ 1,000 g. Of these, 12 were<26
weeks and 17 were≥ 26 weeks GA. Eleven had BWof< 800 g and
18 were ≥ 800 g. The mean (SD) of birth weight and gestational
age was 801 (196.8) grams and 26 5/7 (1.61) weeks respectively.
Twenty-one babies received complete course of steroids, 6 partial
and 2 no steroids. Mode of delivery was C-section in twenty-
three and vaginal in six. The first feeding occurred at mean day of
life 3.
Table 1 shows mean (SD) of serial gastric pH measurements
with the in vitro method for each day over time by GA groups
(<26 and ≥26 weeks). The mean Coefficient of variation (CV)
for the measurements across the time period was 1.16%. Table 2
shows that antenatal steroid use and mode of delivery did not
affect gastric pH.
DISCUSSION
In this study we were able to measure serially gastric pH in
preterm babies by a non-invasivemethod.Most studies measured
gastric pH by using a 24 h pH probe for shorter duration; i.e.,
a few days (2, 3, 8, 10). Unlike other studies, we were able
to measure gastric pH not only on first day but intermittently
over a longer period of time in critically ill preterm babies thus
establishing the evolution of gastric acidity in ELBW infants.
Our study showed that gastric pH was acidic on day 1 and
remained constant up to 4 weeks. An earlier study using in vivo
method showed that there was a decrease in intragastric pH
measured from day 1 to day 16 in infants with < 28 GA and
showed that as the infants became more mature, both in terms
of gestation and postnatal age, there was decrease in intragastric
pH (2). In contrast, we found no difference in gastric pH between
the GA groups over time.
Earlier study showed that babies who received antenatal
steroids had clinical evidence of gastro-esophageal reflux and
the gastric pH was acidic. They speculated that repeated use
of antenatal steroids disrupt the normal neuronal maturation
of the esophageal body and lower esophageal sphincter, thereby
predisposing the infant to an increased incidence of gastro
esophageal reflux (5). Studies on gastro esophageal reflux
most often employed the esophageal pH measurement by a
catheter or measurement of esophageal impedance by multiple
intraluminal impedance (MII) catheter (9, 10). Our study showed
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TABLE 2 | Mean pH and Standard deviation (SD) over period of time by antenatal steroid use and mode of delivery.
Characteristics Day 1 Day 3 Day 5 Day 7 Day 14 Day 21 Day 28
No antenatal
Steroids (N=8)
5.03
(1.49)
4.74
(1.01)
4.08
(1.13)
3.44
(1.03)
4.28
(1.29)
4.60
(0.73)
5.17
(0.75)
Yes antenatal
Steroids (N=21)
4.39
(2.49)
4.32
(1.93)
4.54
(1.72)
3.70
(1.67)
3.80
(1.42)
4.03
(1.22)
4.50
(1.33)
C-section
(N=23)
4.92
(2.67)
4.48
(1.78)
4.37
(1.69)
3.70
(1.56)
4.11
(1.35)
4.13
(1.15)
4.59
(1.26)
Vaginal
(N=6)
4.97 4.36
(1.3)
3.95
(1.09)
3.30
(1.41)
3.32
(1.39)
4.33
(1.15)
5.04
(1.10)
no difference in gastric pH in relation to antenatal steroid use,
though most of the babies in our study had complete course
antenatal steroids and only 8 had partial or no steroids and
our study was not designed to address the potential of in vitro
pH measurement technique to be employed to study gastro
esophageal reflux.
Miclat et al. reported that gastric pH was lower after
vaginal delivery compared to cesarean section delivery. This
was attributed to increased response to stress associated with
labor and vaginal delivery as gastric secretion is regulated by
both nervous and hormonal mechanisms, the nervous regulation
being effected primarily through the parasympathetic fibers of the
vagus nerves. They postulated that pressure phenomena, most
likely on the fetal head, initiate vagal stimulation and gastric
secretion (6). There was no difference in gastric pH between
cesarean section and vaginal delivery in our study.
This study shows feasibility of in vitro gastric pH
measurement, a simple non-invasive bedside test which
allows serial measurements even in sick babies. Gastric pH values
in preterm babies showed functional maturation and pH was
acidic on day 1 and remained relatively constant throughout
study period. These findings indicate that preterm infants can
produce enough acid to lower gastric pH even from day 1 and
there is not a progressive decline indicating that maturity appears
to be attained at birth even in low birth weight preterm neonates
< 28 weeks gestational age. We believe the method utilized
in our study offers the advantage of non-invasive monitoring.
In contrast, the current gold standard for pH measurement is
relatively invasive and mostly utilized with advanced postnatal
age. The proposed non-invasive method can be utilized in
smaller extremely preterm infants and affords more frequent
testing and serial measurement, spread over days and weeks.
This method is valuable as it can guide clinician’s decision
making and limit acid suppression use in extremely preterm
infants.
Study Limitations
We limited our enrollment to very premature ELBW infants;
therefore we have no results on pH by the in vitro method in
more mature infants. Another limitation is that we did not collect
data on the causes of prematurity (such as chorioamnionitis
and pre-eclampsia), type of feeds, apnea/bradycardia events and
medications. Our number of infants studied was small; a larger
number will be needed to apply this in vitro method in practice.
Finally, we also did not perform comparison studies of this
method and the gold standard in vivomethod.
CONCLUSION
The in vitromethod of measuring gastric acid pHmay be a useful
noninvasive bedside tool in NICU. However further studies need
to be done to establish its application in clinical practice.
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